These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 19048196

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evaluation systems for anti-HCV drugs.
    Moriishi K, Matsuura Y.
    Adv Drug Deliv Rev; 2007 Oct 10; 59(12):1213-21. PubMed ID: 17720275
    [Abstract] [Full Text] [Related]

  • 4. Recent advances in the discovery of small molecule therapies for HCV.
    Myles DC.
    Curr Opin Drug Discov Devel; 2001 Jul 10; 4(4):411-6. PubMed ID: 11727306
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The design of drugs for HIV and HCV.
    De Clercq E.
    Nat Rev Drug Discov; 2007 Dec 10; 6(12):1001-18. PubMed ID: 18049474
    [Abstract] [Full Text] [Related]

  • 7. Discovery of highly potent small molecule Hepatitis C Virus entry inhibitors.
    Mittapalli GK, Jackson A, Zhao F, Lee H, Chow S, McKelvy J, Wong-Staal F, Macdonald JE.
    Bioorg Med Chem Lett; 2011 Nov 15; 21(22):6852-5. PubMed ID: 21978675
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Challenges and successes in developing new therapies for hepatitis C.
    De Francesco R, Migliaccio G.
    Nature; 2005 Aug 18; 436(7053):953-60. PubMed ID: 16107835
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Novel interferons for treatment of hepatitis C virus.
    Clark V, Nelson DR.
    Clin Liver Dis; 2009 Aug 18; 13(3):351-63. PubMed ID: 19628153
    [Abstract] [Full Text] [Related]

  • 14. Cyclic phosphoramidates as prodrugs of 2'-C-methylcytidine.
    Meppen M, Pacini B, Bazzo R, Koch U, Leone JF, Koeplinger KA, Rowley M, Altamura S, Di Marco A, Fiore F, Giuliano C, Gonzalez-Paz O, Laufer R, Pucci V, Narjes F, Gardelli C.
    Eur J Med Chem; 2009 Sep 18; 44(9):3765-70. PubMed ID: 19493593
    [Abstract] [Full Text] [Related]

  • 15. Cellular models for the screening and development of anti-hepatitis C virus agents.
    Gondeau C, Pichard-Garcia L, Maurel P.
    Pharmacol Ther; 2009 Oct 18; 124(1):1-22. PubMed ID: 19555718
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High-throughput screening of HCV RNA replication inhibitors by means of a reporter replicon system.
    Hao W, Duggal R.
    Methods Mol Biol; 2009 Oct 18; 510():243-50. PubMed ID: 19009266
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The design, synthesis, and antiviral activity of 4'-azidocytidine analogues against hepatitis C virus replication: the discovery of 4'-azidoarabinocytidine.
    Smith DB, Kalayanov G, Sund C, Winqvist A, Pinho P, Maltseva T, Morisson V, Leveque V, Rajyaguru S, Le Pogam S, Najera I, Benkestock K, Zhou XX, Maag H, Cammack N, Martin JA, Swallow S, Johansson NG, Klumpp K, Smith M.
    J Med Chem; 2009 Jan 08; 52(1):219-23. PubMed ID: 19055482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.